175 related articles for article (PubMed ID: 17315986)
1. Trifluoroacetyl-HYNIC peptides: synthesis and 99mTc radiolabeling.
Surfraz MB; King R; Mather SJ; Biagini SC; Blower PJ
J Med Chem; 2007 Mar; 50(6):1418-22. PubMed ID: 17315986
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
von Guggenberg E; Behe M; Behr TM; Saurer M; Seppi T; Decristoforo C
Bioconjug Chem; 2004; 15(4):864-71. PubMed ID: 15264875
[TBL] [Abstract][Full Text] [Related]
3. Solid-phase synthesis of peptide radiopharmaceuticals using Fmoc-N-epsilon-(hynic-Boc)-lysine, a technetium-binding amino acid: application to Tc-99m-labeled salmon calcitonin.
Greenland WE; Howland K; Hardy J; Fogelman I; Blower PJ
J Med Chem; 2003 Apr; 46(9):1751-7. PubMed ID: 12699393
[TBL] [Abstract][Full Text] [Related]
4. A technetium intermediate specifically promotes deprotection of trifluoroacetyl HYNIC during radiolabelling under mild conditions.
Surfraz MB; Biagini SC; Blower PJ
Dalton Trans; 2008 Jun; (22):2920-2. PubMed ID: 18493625
[TBL] [Abstract][Full Text] [Related]
5. Confirmation of hydrazone formation in HYNIC-peptide conjugate preparation, and its hydrolysis during labeling with (99m)Tc.
Gandomkar M; Najafi R; Shafiei M; Ebrahimi SE
Appl Radiat Isot; 2007 Jul; 65(7):805-8. PubMed ID: 17467277
[TBL] [Abstract][Full Text] [Related]
6. Chemoselective hydrazone formation between HYNIC-functionalized peptides and (18)F-fluorinated aldehydes.
Bruus-Jensen K; Poethko T; Schottelius M; Hauser A; Schwaiger M; Wester HJ
Nucl Med Biol; 2006 Feb; 33(2):173-83. PubMed ID: 16546671
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of leukotriene B4 antagonists labeled with In-111 or Tc-99m to image infectious and inflammatory foci.
Broekema M; van Eerd JJ; Oyen WJ; Corstens FH; Liskamp RM; Boerman OC; Harris TD
J Med Chem; 2005 Oct; 48(20):6442-53. PubMed ID: 16190770
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of oxytocin HYNIC derivatives as potential diagnostic agents for breast cancer.
Miranda-Olvera AD; Ferro-Flores G; Pedraza-López M; de Murphy CA; De León-Rodríguez LM
Bioconjug Chem; 2007; 18(5):1560-7. PubMed ID: 17665873
[TBL] [Abstract][Full Text] [Related]
9. Radiolabeling of annexin A5 with (99m)Tc: comparison of HYNIC-Tc vs. iminothiolane-Tc-tricarbonyl conjugates.
Biechlin ML; Bonmartin A; Gilly FN; Fraysse M; du Moulinet d'Hardemare A
Nucl Med Biol; 2008 Aug; 35(6):679-87. PubMed ID: 18678353
[TBL] [Abstract][Full Text] [Related]
10. Pre-clinical evaluation of a new indirectly labeled ⁹⁹mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator.
Yu F; Lü ML; Zhang XP; Fu D; Hou M; Cai HD; Li D; Wang J; Yuan XY; Lü ZW; Dong F
Chin Med J (Engl); 2012 Jul; 125(14):2538-42. PubMed ID: 22882936
[TBL] [Abstract][Full Text] [Related]
11. Microwave-assisted synthesis of HYNIC protected analogue for 99mTc labeled antibody.
García MF; Calzada V; Camacho X; Goicochea E; Gambini JP; Quinn TP; Porcal W; Cabral P
Curr Radiopharm; 2014; 7(2):84-90. PubMed ID: 25429778
[TBL] [Abstract][Full Text] [Related]
12. Cyclic minigastrin analogues for gastrin receptor scintigraphy with technetium-99m: preclinical evaluation.
von Guggenberg E; Sallegger W; Helbok A; Ocak M; King R; Mather SJ; Decristoforo C
J Med Chem; 2009 Aug; 52(15):4786-93. PubMed ID: 19591486
[TBL] [Abstract][Full Text] [Related]
13. 99mTc-labeling of HYNIC-conjugated cyclic RGDfK dimer and tetramer using EDDA as coligand.
Wang J; Kim YS; Liu S
Bioconjug Chem; 2008 Mar; 19(3):634-42. PubMed ID: 18281926
[TBL] [Abstract][Full Text] [Related]
14. Lys and Arg in UBI: a specific site for a stable Tc-99m complex?
Meléndez-Alafort L; Ramírez Fde M; Ferro-Flores G; Arteaga de Murphy C; Pedraza-López M; Hnatowich DJ
Nucl Med Biol; 2003 Aug; 30(6):605-15. PubMed ID: 12900286
[TBL] [Abstract][Full Text] [Related]
15. Docking, synthesis, in-vitro evaluation, and optimization of reaction conditions for direct radiolabeling of CGPRPPC with technetium-99m through the GAGG sequence.
Mosayebnia M; Hajiramezanali M; Shahhosseini S; Hajiagha Bozorgi A; Kobarfard F; Rezaeianpour S
Nucl Med Commun; 2018 Nov; 39(11):976-982. PubMed ID: 30212401
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Biological Evaluation of Cyclic [
Rezaeianpour S; Bozorgi AH; Moghimi A; Almasi A; Balalaie S; Ramezanpour S; Nasoohi S; Mazidi SM; Geramifar P; Bitarafan-Rajabi A; Shahhosseini S
Mol Imaging Biol; 2017 Apr; 19(2):256-264. PubMed ID: 27632423
[TBL] [Abstract][Full Text] [Related]
17. Neurotensin(8-13) analogue: radiolabeling and biological evaluation using different chelators.
Teodoro R; Faintuch BL; Núñez EG; Queiróz RG
Nucl Med Biol; 2011 Jan; 38(1):113-20. PubMed ID: 21220134
[TBL] [Abstract][Full Text] [Related]
18. Preparation, 99mTc-labeling, and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr3]octreotide.
Decristoforo C; Mather SJ
Bioconjug Chem; 1999; 10(3):431-8. PubMed ID: 10346875
[TBL] [Abstract][Full Text] [Related]
19. A new strategy for the preparation of peptide-targeted technetium and rhenium radiopharmaceuticals. The automated solid-phase synthesis, characterization, labeling, and screening of a peptide-ligand library targeted at the formyl peptide receptor.
Stephenson KA; Banerjee SR; Sogbein OO; Levadala MK; McFarlane N; Boreham DR; Maresca KP; Babich JW; Zubieta J; Valliant JF
Bioconjug Chem; 2005; 16(5):1189-95. PubMed ID: 16173797
[TBL] [Abstract][Full Text] [Related]
20. Control of radioactivity pharmacokinetics of 99mTc-HYNIC-labeled polypeptides derivatized with ternary ligand complexes.
Ono M; Arano Y; Mukai T; Saga T; Fujioka Y; Ogawa K; Kawashima H; Konishi J; Saji H
Bioconjug Chem; 2002; 13(3):491-501. PubMed ID: 12009938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
